Androgen hypersensitivity in prostate cancer: molecular perspectives on androgen deprivation therapy strategies.
about
The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cellsCancer/testis antigens and urological malignanciesThe present and future of prostate cancer urine biomarkers.Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis.Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation.
P2860
Androgen hypersensitivity in prostate cancer: molecular perspectives on androgen deprivation therapy strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Androgen hypersensitivity in p ...... eprivation therapy strategies.
@en
Androgen hypersensitivity in p ...... eprivation therapy strategies.
@nl
type
label
Androgen hypersensitivity in p ...... eprivation therapy strategies.
@en
Androgen hypersensitivity in p ...... eprivation therapy strategies.
@nl
prefLabel
Androgen hypersensitivity in p ...... eprivation therapy strategies.
@en
Androgen hypersensitivity in p ...... eprivation therapy strategies.
@nl
P2093
P2860
P356
P1433
P1476
Androgen hypersensitivity in p ...... deprivation therapy strategies
@en
P2093
Donal Hollywood
John P Keane
Ruth Foley
Thomas H Lynch
P2860
P304
P356
10.1002/PROS.21266
P50
P577
2010-10-13T00:00:00Z